---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-217434"
form_type: "8-K"
ticker: "KYTX"
cik: "0001994702"
company_name: "Kyverna Therapeutics, Inc."
filed_at: "2025-09-25T23:59:59+00:00"
generated_at: "2026-05-17T05:42:52.294499+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Director Steve Liapis resigns from Kyverna board effective Sept 30, 2025

## Summary
- Steve Liapis, Ph.D. notified the board of his resignation effective September 30, 2025.
- Resignation is not due to any disagreement with the company's operations, policies, or practices.
- Board size will be reduced from eight to seven directors upon resignation.
- Christi Shaw, a current board member, appointed to the Audit Committee to fill the vacancy.

## SEC filing metadata
- accession: 0001193125-25-217434
- form_type: 8-K
- ticker: KYTX
- cik: 0001994702
- company_name: Kyverna Therapeutics, Inc.
- filed_at: 2025-09-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1994702/000119312525217434/0001193125-25-217434-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1994702/000119312525217434/kytx-20250919.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-217434
- JSON: https://secwatch.observer/filing/0001193125-25-217434.json
- Plain text: https://secwatch.observer/filing/0001193125-25-217434.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.